Tristel plc

("Tristel" or the "Company")

Analyst and Investor presentation

Re. news of FDA De Novo approval for Tristel ULT as a high level disinfectant

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Company will hold a presentation for analysts and investors following this morning's announcement that Tristel ULT was approved by the FDA as a high level disinfectant for use on endocavity ultrasound probes and skin surface transducers.

Paul Swinney, CEO, and Liz Dixon, CFO, will provide details of the Company's North America Commercial Strategy in a presentation which is open to all existing and potential shareholders, as well as analysts.

The live presentation will take place on the Investor Meet Company platform at 4.30pm today, Monday 5 June 2023, and a replay facility will also be available shortly afterwards. Questions can be submitted at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Tristel plc to register for the presentation via: https://www.investormeetcompany.com/tristel-plc/register-investor

For further information please contact: